Intra-pericardial thrombin injection for post-infarction left ventricular free wall rupture

Area of Science:

• Cardiology
• Cardiac Surgery
• Medical Innovation

Background:

• Left ventricular free wall rupture (LVFWR) is a rare but fatal complication following acute myocardial infarction (MI).
• Existing treatments for LVFWR, including surgical repair and medical management, carry significant risks and variable outcomes.
• Cardiac tamponade frequently complicates LVFWR, necessitating urgent intervention.

Purpose of the Study:

• To present a novel therapeutic approach for managing left ventricular free wall rupture (LVFWR) with cardiac tamponade.
• To evaluate the efficacy and safety of intra-pericardial thrombin injection as a treatment modality for LVFWR.

Main Methods:

• A case report detailing the management of a patient with acute myocardial infarction complicated by LVFWR and cardiac tamponade.
• Administration of intra-pericardial thrombin injection as a minimally invasive therapeutic intervention.
• Monitoring of patient's hemodynamic status and echocardiographic findings post-intervention.

Main Results:

• The intra-pericardial thrombin injection resulted in successful cessation of bleeding and resolution of cardiac tamponade.
• The patient demonstrated a favorable clinical outcome with hemodynamic stability following the procedure.
• No major adverse events or complications were observed during the follow-up period.

Conclusions:

• Intra-pericardial thrombin injection represents a promising and potentially life-saving alternative treatment for left ventricular free wall rupture (LVFWR) with cardiac tamponade.
• This minimally invasive technique may offer a favorable risk-benefit profile compared to traditional surgical interventions.
• Further research and larger studies are warranted to establish the role of thrombin injection in the management of LVFWR.